A Prospective, Single-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to the Saline Placebo Injection in the Treatment of Plantar Fasciitis
Active, no longer recruiting
Phase of Trial: Phase II/III
Latest Information Update: 10 Jul 2018
At a glance
- Drugs DHACM (Primary)
- Indications Plantar fasciitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors MiMedx
- 28 Jun 2018 Status changed from recruiting to active, no longer recruiting.
- 24 Oct 2017 Planned End Date changed from 1 Jul 2017 to 1 Dec 2018.
- 24 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Oct 2018.